Literature DB >> 6978166

Pharmacological evidence for the involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC).

D Chitour, A H Dickenson, D Le Bars.   

Abstract

The involvement of serotonergic mechanisms in diffuse noxious inhibitory controls (DNIC) acting on dorsal horn convergent neurones has been studied in the anaesthetized rat. 35 neurones activated by transcutaneous electrical stimulation of their hindpaw receptive fields giving clear large A-fibre and C-fibre responses were recorded. These activities were conditioned by DNIC, evoked by either noxious heat applied to the tail or noxious pinch of the nose. Cinanserin (4 mg/kg i.v.) and metergoline (5 mg/kg i.v.), serotonin (5-HT) receptor blockers, strongly reduced the inhibitory effects of DNIC whilst having no significant effect on the non-conditioned responses. 5-Hydroxytryptophan, a precursor of 5-HT synthesis, significantly potentiated the effect of DNIC. These results indicate an important role for descending serotonergic pathways in DNIC. The functional role of this system is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978166     DOI: 10.1016/0006-8993(82)90718-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  GABAergic modulation of diffuse noxious inhibitory controls (DNIC): a test by use of lorazepam.

Authors:  Miriam Kunz; Kirsten Elisabeth Scholl; Ulrich Schu; Stefan Lautenbacher
Journal:  Exp Brain Res       Date:  2006-07-01       Impact factor: 1.972

2.  Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing.

Authors:  Christopher D King; Burel Goodin; Lindsay L Kindler; Robert M Caudle; Robert R Edwards; Nikolaus Gravenstein; Joseph L Riley; Roger B Fillingim
Journal:  J Behav Med       Date:  2012-04-26

Review 3.  Conditioned pain modulation: a predictor for development and treatment of neuropathic pain.

Authors:  Yelena Granovsky
Journal:  Curr Pain Headache Rep       Date:  2013-09

4.  The effects of 5-HT4 receptor agonist, mosapride citrate, on visceral hypersensitivity in a rat model.

Authors:  Jae Woong Lee; Ki Woon Sung; Oh Young Lee; Seo Eun Lee; Chong Il Sohn
Journal:  Dig Dis Sci       Date:  2012-03-17       Impact factor: 3.199

Review 5.  Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.

Authors:  A H Dickenson; D Le Bars
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

Review 6.  Neuromuscular function in painful knee osteoarthritis.

Authors:  Carol A Courtney; Michael A O'Hearn; T George Hornby
Journal:  Curr Pain Headache Rep       Date:  2012-12

7.  Differences in suprathreshold heat pain responses and self-reported sleep quality between patients with temporomandibular joint disorder and healthy controls.

Authors:  M C Ribeiro-Dasilva; B R Goodin; R B Fillingim
Journal:  Eur J Pain       Date:  2012-02-17       Impact factor: 3.931

8.  Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.

Authors:  Una D McCann; Robert R Edwards; Michael T Smith; Kristen Kelley; Michael Wilson; Francis Sgambati; George Ricaurte
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

9.  The important role of CNS facilitation and inhibition for chronic pain.

Authors:  Roland Staud
Journal:  Int J Clin Rheumtol       Date:  2013-12-01

10.  Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation.

Authors:  J-M Sabaté; D Bouhassira; C Poupardin; A Wagner; Y Loria; B Coffin
Journal:  Neurogastroenterol Motil       Date:  2007-11-14       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.